Eye inflammation can strike suddenly, leaving patients with redness, pain, and blurred vision. Anterior uveitis, affecting the iris and ciliary body, ranks among the most common forms of intraocular inflammation, with published studies reporting it accounts for anywhere between 30% and roughly 90% of all uveitis cases depending on the population studied, rather than a single fixed figure. In Turkey, ophthalmologists employ a multimodal approach combining topical corticosteroids, cycloplegic agents, and targeted systemic therapy when underlying causes (infectious, autoimmune, or idiopathic) are identified.
Certified facilities offer same-day slit lamp examination, anterior chamber imaging, and rapid laboratory screening for systemic diseases (tuberculosis, syphilis, HLA-B27 positivity) that often trigger inflammation. Early intervention within 48 hours of symptom onset is generally associated with a lower risk of posterior synechiae, cataract formation, and secondary glaucoma. Treatment packages, including specialist consultations, imaging, and initial medication protocols, typically range from 800 to 2,200 euros, compared to 2,500 to 6,000 euros in Western Europe, reflecting operational efficiency rather than compromised standards.
